LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Rescue of MHC-1 antigen processing machinery by down-regulation in expression of IGF-1 in human glioblastoma cells.

    Yuexin Pan / Jerzy Trojan / Yajun Guo / Donald D Anthony

    PLoS ONE, Vol 8, Iss 3, p e

    2013  Volume 58428

    Abstract: Escape from immune recognition has been hypothesized to be a factor in carcinogenesis. It may be mediated for many cancers through down-regulation in the MHC class 1 antigen processing and presentation pathway. TAP-1, TAP-2, tightly linked to LMP-2 and ... ...

    Abstract Escape from immune recognition has been hypothesized to be a factor in carcinogenesis. It may be mediated for many cancers through down-regulation in the MHC class 1 antigen processing and presentation pathway. TAP-1, TAP-2, tightly linked to LMP-2 and LMP-7 are multiple components of the endogenous, antigen presentation pathway machinery. We addressed the question of alterations in this pathway in human Glioblastoma (HGB) and of its relationship to modulation in expression of IGF-1 that is highly expressed in this cancer. Deficiencies in expression of TAP-1 were demonstrated by RT-PCR and/or by immuno-flow cytometry in the HGB cell line T98G obtained from ATCC, and in 3 of 4 human cell lines established from patients with Glioblastoma Multiforme. Deficiencies in expression of TAP-2 were observed in 3 of 4, deficiencies in expression of LMP-2 in 4 of 4 and deficiencies in LMP-7 in 3 of 4 HGB cell lines examined by RT-PCR and Western blot. Following down-regulation of IGF-1 by transfection with the pAnti IGF-1 vector that expresses IGF-1 RNA in antisense orientation, or by the exogenous addition of IGF-1 receptor monoclonal antibody to cell culture media, the deficiencies in components of the MHC-1 antigen presentation pathway were up-regulated and/or rescued in all HGB cell lines tested. Moreover, this up-regulation in expression was aborted by addition of 100 ng/ml of IGF-1 to the culture media. Unlike in the case of IFN-γ, the restoration of TAP-1 and LMP-2 by down-regulation of IGF-1 in Glioblastoma cells was not correlated to the tyrosine phosphorylation of STAT 1. In summary, the simultaneous reversion in expression of the multiple constituents of MHC-1 antigen processing path and up-regulation in expression of MHC-1 occurring with down-regulation in IGF-1 may have a role in reinforcement of immunity against tumor antigen(s) in some animal cancers and in humans with Glioblastoma Multiforme.
    Keywords Medicine ; R ; Science ; Q
    Subject code 570
    Language English
    Publishing date 2013-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Immunotherapy of Malignant Tumors Using Antisense Anti-IGF-I Approach

    Annabelle Trojan / Lina M. Jay / Heliodor Kasprzak / Donald D. Anthony / Jerzy Trojan

    Journal of Cancer Therapy, Vol 05, Iss 07, Pp 685-

    Case of Glioblastoma

    2014  Volume 705

    Abstract: The review article describes the criteria established for methodology of antisense anti IGF-I therapy of malignant tumors, particularly of glioblastoma. The cancer patients, after classical therapy of surgery, radiotherapy and chemotherapy, have ... ...

    Abstract The review article describes the criteria established for methodology of antisense anti IGF-I therapy of malignant tumors, particularly of glioblastoma. The cancer patients, after classical therapy of surgery, radiotherapy and chemotherapy, have undergone the injection of genetically modified autologous malignant cells—transfected by IGF-I antisense/triple helix expression vectors. For all cancer patients supervised for up to 19 months, the period corresponding to minimum survival of glioblastoma patients, the following common immune criteria for “anti IGF-I” strategy were admitted: 1) characteristics of cell “vaccines”—absence of IGF-I and expression of MHC-I in cloned transfected cells; 2) the peripheral blood lymphocytes, PBL cells, removed after every of two successive vaccinations, demonstrate an increasing level of CD8 + and CD8 + 28 + molecules (with a switch from CD8 + 11b + to CD8 + 11b - ).
    Keywords Immunogene Therapy ; Malignant Tumors ; Glioblastoma ; IGF-I ; Antisense ; Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282 ; Internal medicine ; RC31-1245 ; Medicine ; R
    Language English
    Publishing date 2014-06-01T00:00:00Z
    Publisher Scientific Research Publishing
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Epistemological experience in developing of biomolecular technology for immunogene therapy strategy

    Tatiana Castillo / Annabelle Trojan / Maria Claudia Noguera / Lina Manuela Jay / Cecilia Crane / Alexander Shevelev / Alvaro Alvarez / Heliodor Kasprzak / Gonzalo Melo / Pedro Jose Penagos / Beatriz Helena Aristizabal / Ignacio Briceño / Adis Ayala / Huynh T. Duc / Jerzy Trojan

    Revista Científica, Vol 2, Iss 25, Pp 228-

    2016  Volume 240

    Abstract: We have been faced with a 40 year long challenge: how to establish tools that can be applied in the treatment of brain tumor - glioblastoma (100% fatal) - using our knowledge of evolution, chemistry of proteins, genetics, molecular biology and immunology. ...

    Abstract We have been faced with a 40 year long challenge: how to establish tools that can be applied in the treatment of brain tumor - glioblastoma (100% fatal) - using our knowledge of evolution, chemistry of proteins, genetics, molecular biology and immunology. An efficient strategy targeting growth factor IGF-I, present in tumor development, was established by construction of vectors expressing either IGF-I antisense RNA or IGF-I RNA forming RNA-DNA triple helix. The vectors introduced in the cancer cells in vitro, enable to completely stop the synthesis of IGF-I: on translation or transcription level, respectively. When injected in vivo, these cells induce an immune anti-tumor effect (CD8+) accompanied by increase of the median survival of patients. The first thesis in Colombia describing the used technology, was presented in Distrital University in February 2016.
    Keywords antisentido ; triple hélice ; IGF-I ; glioma ; CD8+ ; Technology ; T ; Science ; Q
    Language English
    Publishing date 2016-08-01T00:00:00Z
    Publisher Universidad Distrital Francisco José de Caldas
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours

    Jerzy Trojan / Yuexin X. Pan / Ming X. Wei / Adama Ly / Alexander Shevelev / Maciej Bierwagen / Marie-Yvonne Ardourel / Ladislas A. Trojan / Alvaro Alvarez / Christian Andres / Maria C. Noguera / Ignacio Briceno / Beatriz H. Aristizabal / Heliodor Kasprzak / Huynh T. Duc / Donald D. Anthony

    Chemotherapy Research and Practice, Vol

    2012  Volume 2012

    Keywords Therapeutics. Pharmacology ; RM1-950 ; Medicine ; R ; DOAJ:Therapeutics ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Language English
    Publishing date 2012-01-01T00:00:00Z
    Publisher Hindawi Publishing Corporation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Erratum to “Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours”

    Jerzy Trojan / Yuexin X. Pan / Ming X. Wei / Adama Ly / Alexander Shevelev / Maciej Bierwagen / Marie-Yvonne Ardourel / Ladislas A. Trojan / Alvaro Alvarez / Christian Andres / Maria C. Noguera / Ignacio Briceno / Beatriz H. Aristizabal / Heliodor Kasprzak / Huynh T. Duc / Donald D. Anthony

    Chemotherapy Research and Practice, Vol

    2012  Volume 2012

    Keywords Therapeutics. Pharmacology ; RM1-950 ; Medicine ; R ; DOAJ:Therapeutics ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Language English
    Publishing date 2012-01-01T00:00:00Z
    Publisher Hindawi Publishing Corporation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top